SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation – QTRX

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Quanterix and certain of its officers and/or directors have […]

Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Rapid7, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Rapid7, Inc. ("Rapid7" or "the Company") (NASDAQ:RPD) for potential breaches of fiduciary duty on the part of its directors and management. The investigation

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Silvaco Group, Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Silvaco Group, Inc. ("Silvaco" or "the Company") (NASDAQ:SVCO) for violations of the securities laws. The investigation focuses on whether the Company issued false

TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of the securities laws. The investigation focuses on whether the Company issued false

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dave Inc. – DAVE

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Dave INC. ("Dave" or the "Company") (NASDAQ:DAVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Dave and certain of its officers and/or directors have

Shareholders of Rentokil Initial plc Should Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights – RTO

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=124396&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vail Resorts, Inc. – MTN

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Vail Resorts, Inc. ("Vail Resorts" or the "Company") (NYSE:MTN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Vail Resorts and certain of its officers

InventHelp Inventors Develop Newly Designed Table Mat for Seafood Boils (DCD-403)

“We wanted to create a simple and easy way to clean up the table and discard food scraps after eating seafood, during a picnic or other large meal,” said one of two inventors, from Clinton,Md., “so we invented the CRABBY MATT. Our design would offer an improved alternative to traditional tablecloths or covering the table

Swiss startup Risklick launches AI-based software for medical device clinical trials

Protocol AI accelerates clinical trial development and patient access to medical devices Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of its kind and marks a turning point in the medical device industry. It uses artificial intelligence to accelerate

Changes in Nokia Corporation’s own shares

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Nokia CorporationStock Exchange Release22 January 2025 at 18:30 EET Changes in Nokia Corporation's own shares Espoo, Finland – A total of 3 485 335 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with the rules of the plans. The transfer is

Scroll to Top